Levodopa/carbidopa/entacapone in Parkinson’s disease
✍ Scribed by Seeberger, Lauren C; Hauser, Robert A
- Book ID
- 118024143
- Publisher
- Expert Reviews
- Year
- 2009
- Tongue
- English
- Weight
- 894 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1473-7175
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie
## Abstract We aimed to investigate whether treatment with levodopa/carbidopa/entacapone when compared with levodopa/carbidopa improves quality of life in Parkinson's disease (PD) patients with no or minimal, nondisabling motor fluctuations. This is a multicenter, randomized, double‐blind study. On